Retraction notice to “Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta‐analysis”. [Lung Cancer 204 (2025) 108559]

IF 4.4 2区医学 Q1 ONCOLOGY

Lung Cancer Pub Date : 2025-10-01 DOI:10.1016/j.lungcan.2025.108719

Tianyu Shao , Jiayao Yang , Jialu Chen , Yao Zhang , Liumei Shou

引用次数: 0

查看原文本刊更多论文

《抗体-药物偶联成分与adc相关间质性肺疾病发病率相关：一项系统综述和荟萃分析》的撤回通知。[肺癌204(2025)108559]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.